Status:
COMPLETED
Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule
Lead Sponsor:
Emory University
Collaborating Sponsors:
Nihon Medi-Physics Co., Ltd.
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study will look at how the \[18\]FACBC goes into the lung nodules. This will hopefully lead to the development of better imaging techniques to look at lung nodules. \[18\]FACBC is not approved by...
Detailed Description
This is a study that will test a compound (chemical substance) that has a small amount of radioactivity attached to it. This substance has a natural tendency to go to tumor cells, as has been shown in...
Eligibility Criteria
Inclusion
- Patients must be 18 years of age or older.
- Patients with a history of cancer who have a solitary pulmonary nodule between 1-3 cm in short axis with clinical and CT characteristics warranting surgical removal (see below).
- Clinical, laboratory, or diagnostic imaging findings on CT or 18F-FDG PET-CT do not suggest the possibility of the SPN being part of a metastatic process.
- Ability to lie still for PET scanning
- Patients must be able to provide written informed consent.
Exclusion
- Age less than 18.
- Active carcinoma with known metastatic disease.
- Size of primary lesion less than 1 cm or greater than 3 cm
- Not a candidate for surgical resection or biopsy based upon clinical condition or discovery of metastatic disease which would preclude surgical therapy.
- Inability to lie still for PET scanning
- Cannot provide written informed consent
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01502670
Start Date
May 1 2009
End Date
January 1 2013
Last Update
November 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322